NP47827 Multiple Sclerosis Medicines
- Buyer
- The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Published
- 2026-10-26
- Deadline
- Not provided
- Sources
- UK_FTS
- Value
- 30403887.0 GBP
Description
The description is in the source language.
The Authority seeks to establish a Framework Agreement covering Multiple Sclerosis medicines. The range of medicines under consideration for inclusion in the Framework Agreement are listed below (subject to removal or replacement due to a continually shifting litigation landscape): Glatiramer acetate Interferon beta-1a Teriflunomide Dimethyl fumarate Fingolimod Natalizumab Cladribine
CPV: 33600000
Membership
Read notice previews free of charge. Official notice and document links, construction permits and personal MCP access require an active paid membership.
Read